Display options
Share it on

J Radiosurg SBRT. 2011;1(3):237-245.

Gamma knife radiosurgery for intralabyrinthine schwannomas.

Journal of radiosurgery and SBRT

Nicolas Massager, Landry Drogba, Carine Delbrouck, Nadir Benmebarek, Françoise Desmedt, Daniel Devriendt

Affiliations

  1. Gamma Knife Center, Erasme University Hospital, Brussels, Belgium.
  2. Clinic of Stereotactic and Functional Neurosurgery, Erasme University Hospital, Brussels, Belgium.
  3. Department of Oto-Rhino-Laryngology, Erasme University Hospital, Brussels, Belgium.

PMID: 29296322 PMCID: PMC5725321

Abstract

OBJECT: To analyze indications and technical specificities of treatment of intralabyrinthine schwannoma (ILS) by Gamma Knife radiosurgery.

METHODS: Six patients were treated by Gamma Knife irradiation for a schwannoma arising from the cochleo-vestibular structures. Patients presented hearing worsening at different stages, tinnitus, imbalance and/or vertigo.

RESULTS: ILS was intravestibular/intracochlear/intravestibulocochlear/ transmacular in respectively 2/1/2/1 patients. We cover the entire tumor volume with a margin prescription dose of 12-Gy. The tumor volume remained unchanged at last follow-up in all cases; for 4 patients with functional hearing still present before treatment, the audiological status remained stable in 2 patients, worsened moderately in 1 patientand worsened to cophosis in 1 patient. No patient experienced worsening of tinnitus, imbalance or vertigo after irradiation.

CONCLUSIONS: Gamma Knife treatment of ILS is technically feasible without risk thanks to the precision of current robotized Gamma Knife devices. Patients treated radiosurgically avoid some of the risks of microsurgery, could in some cases maintain useful hearing and prevent further symptoms worsening.

Keywords: Gamma Knife; Intralabyrinthine schwannomas; classification; cochlea; irradiation; outcome; radiosurgery; treatment; vestibule

References

  1. Ann Otolaryngol Chir Cervicofac. 1998 Feb;115(1):35-41 - PubMed
  2. Otol Neurotol. 2004 Mar;25(2):160-7 - PubMed
  3. Neurosurgery. 2010 Nov;67(5):1335-40; discussion 1340 - PubMed
  4. Stereotact Funct Neurosurg. 2009;87(3):137-42 - PubMed
  5. Neurosurgery. 2008 Dec;63(6):1054-62; discussion 1062-3 - PubMed
  6. Eur Arch Otorhinolaryngol. 2009 Jan;266(1):143-5 - PubMed
  7. Ann Otol Rhinol Laryngol. 1988 Jan-Feb;97(1):55-66 - PubMed
  8. Laryngoscope. 1999 Oct;109(10):1626-31 - PubMed
  9. Otol Neurotol. 2003 Mar;24(2):299-307 - PubMed
  10. J Neurosurg. 2007 Oct;107(4):733-9 - PubMed
  11. Otol Neurotol. 2005 Sep;26(5):1085-6 - PubMed
  12. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):845-51 - PubMed
  13. Acta Otorrinolaringol Esp. 2007 Feb;58(2):70-2 - PubMed
  14. Auris Nasus Larynx. 2007 Dec;34(4):459-63 - PubMed
  15. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1331-40 - PubMed
  16. Am J Otol. 1999 May;20(3):381-5 - PubMed
  17. Auris Nasus Larynx. 2008 Mar;35(1):131-6 - PubMed
  18. Acta Otorhinolaryngol Belg. 2003;57(3):197-204 - PubMed
  19. J Neurosurg. 2000 Dec;93 Suppl 3:219-22 - PubMed
  20. AJNR Am J Neuroradiol. 2008 May;29(5):898-905 - PubMed

Publication Types